Magnetic Targeting of Human Peripheral Blood CD133+ Cells for Skeletal Muscle Regeneration

被引:0
作者
Ohkawa, Shingo [1 ]
Kamei, Naosuke [2 ,3 ]
Kamei, Goki [2 ]
Shi, Ming [1 ]
Adachi, Nobuo [2 ]
Deie, Masataka [4 ]
Ochi, Mitsuo [2 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Programs Appl Biomed,Div Clin Med Sci, Hiroshima 7348551, Japan
[2] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Orthopaed Surg, Hiroshima 7348551, Japan
[3] Hiroshima Univ Hosp, Div Regenerat & Med, Hiroshima, Japan
[4] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Musculoskeletal Funct Res & Regenerat, Hiroshima 7348551, Japan
关键词
ANTIFIBROSIS AGENT; STEM-CELLS; RECOVERY; PROMOTE; GROWTH; INJURY; TRANSPLANTATION; ENHANCEMENT;
D O I
10.1089/ten.tec.2012.0431
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Skeletal muscle injuries often leave lasting functional damage or pain. Muscle injuries are routinely treated conservatively, but the most effective treatment to promote the repair of injured muscles has not yet been established. Our previous report demonstrated that human peripheral blood-derived CD133(+) cell transplantation to rat skeletal muscle injury models inhibited fibrosis and enhanced myogenesis after injury. However, the acquisition of a sufficient number of cells remains the limitation for clinical application, as the CD133(+) population is rare in human blood. In this study, we applied a magnetic cell targeting system to accumulate transplanted cells in the muscle injury site and to enhance the regenerative effects of CD133(+) cell transplantation, focusing on the fact that CD133(+) cells are labeled with a magnetic bead for isolation. For the magnetic cell targeting, the magnet field generator was set up to adjust the peak of the magnetic gradient to the injury site of the tibialis anterior muscle, and 1 x 10(4) human peripheral blood CD133(+) cells were locally injected into the injury site. This cell number is 10% of that used in the previous study. In another group, the same number of CD133(+) cells was injected without magnetic force. The CD133(+) cells transplanted with the magnetic force were more accumulated in the muscle injury site compared with the CD133(+) cells transplanted without the magnetic force. In addition, the transplantation of CD133(+) cells under the magnetic control inhibited fibrous scar formation and promoted angiogenesis and myogenesis, and also upregulated the mRNA expression of myogenic transcription factors, including Pax7, MyoD1 and Myogenin. However, the transplantation of CD133(+) cells without the magnetic force failed to demonstrate these effects. Thus, our magnetic cell targeting system enables transplantation of a limited number of CD133(+) cells to promote the repair of skeletal muscle injury.
引用
收藏
页码:631 / 641
页数:11
相关论文
共 32 条
[1]   The effect of strong static magnetic field on lymphocytes [J].
Aldinucci, C ;
Garcia, JB ;
Palmi, M ;
Sgaragli, G ;
Benocci, A ;
Meini, A ;
Pessina, F ;
Rossi, C ;
Bonechi, C ;
Pessina, GP .
BIOELECTROMAGNETICS, 2003, 24 (02) :109-117
[2]   Transplantation of adipose tissue-derived stromal cells increases mass and functional capacity of damaged skeletal muscle [J].
Bacou, F ;
el Andalousi, RB ;
Daussin, PA ;
Micallef, JP ;
Levin, JM ;
Chammas, M ;
Casteilla, L ;
Reyne, Y ;
Nouguès, J .
CELL TRANSPLANTATION, 2004, 13 (02) :103-111
[3]   Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction - Feasibility and safety [J].
Bartunek, J ;
Vanderheyden, M ;
Vandekerckhove, B ;
Mansour, S ;
De Bruyne, B ;
De Bondt, P ;
Van Haute, I ;
Lootens, N ;
Heyndrickx, G ;
Wijns, W .
CIRCULATION, 2005, 112 (09) :I178-I183
[4]   The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury [J].
Chan, YS ;
Li, Y ;
Foster, W ;
Fu, FH ;
Huard, J .
AMERICAN JOURNAL OF SPORTS MEDICINE, 2005, 33 (01) :43-51
[5]   Bioeffects of moderate-intensity static magnetic fields on cell cultures [J].
Dini, L ;
Abbro, L .
MICRON, 2005, 36 (03) :195-217
[6]   Gamma interferon as an antifibrosis agent in skeletal muscle [J].
Foster, W ;
Li, Y ;
Usas, A ;
Somogyi, G ;
Huard, J .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2003, 21 (05) :798-804
[7]   The use of an antifibrosis agent to improve muscle recovery after laceration [J].
Fukushima, K ;
Badlani, N ;
Usas, A ;
Riano, F ;
Fu, FH ;
Huard, J .
AMERICAN JOURNAL OF SPORTS MEDICINE, 2001, 29 (04) :394-402
[8]   Intramuscular Transplantation of G-CSF-Mobilized CD34+ Cells in Patients With Critical Limb Ischemia: A Phase I/IIa, Multicenter, Single-Blinded, Dose-Escalation Clinical Trial [J].
Kawamoto, Atsuhiko ;
Katayama, Minako ;
Handa, Nobuhiro ;
Kinoshita, Makoto ;
Takano, Haruna ;
Horii, Miki ;
Sadamoto, Kazuyo ;
Yokoyama, Ayumi ;
Yamanaka, Takeharu ;
Onodera, Rie ;
Kuroda, Akiko ;
Baba, Rie ;
Kaneko, Yuichiro ;
Tsukie, Tomio ;
Kurimoto, Yasuo ;
Okada, Yukikatsu ;
Kihara, Yasuki ;
Morioka, Shigefumi ;
Fukushima, Masanori ;
Asahara, Takayuki .
STEM CELLS, 2009, 27 (11) :2857-2864
[9]   Regeneration of peripheral nerve after transplantation of CD133+ cells derived from human peripheral blood [J].
Kijima, Yasumu ;
Ishikawa, Masakazu ;
Sunagawa, Toru ;
Nakanishi, Kazuyoshi ;
Kamei, Naosuke ;
Yamada, Kiyotaka ;
Tanaka, Nobuhiro ;
Kawamata, Seiichi ;
Asahara, Takayuki ;
Ochi, Mitsuo .
JOURNAL OF NEUROSURGERY, 2009, 110 (04) :758-767
[10]   A novel cell delivery system using magnetically labeled mesenchymal stem cells and an external magnetic device for clinical cartilage repair [J].
Kobayashi, Takaaki ;
Ochi, Mitsuo ;
Yanada, Shinobu ;
Ishikawa, Masakazu ;
Adachi, Nobuo ;
Deie, Masataka ;
Arihiro, Koji .
ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2008, 24 (01) :69-76